Directorio de personas
Diego Arango Del Corro

Diego Arango Del Corro

Grado: Doctor/a


darango(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/M-5667-2016

Grupos

Publicaciones

  • Mariadason JM; Augenlicht LH; Arango D

    Microarray analysis in the clinical management of cancer.

    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 17 377-387. .

    [doi:10.1016/s0889-8588(03)00006-6]

  • Augenlicht LH; Mariadason JM; Wilson A; Arango D; Yang W; Heerdt BG; Velcich A

    Short chain fatty acids and colon cancer.

    Journal Of Nutrition 132 -. .

    [doi:10.1093/jn/132.12.3804S]

  • Wilson AJ; Velcich A; Arango D; Kurland AR; Shenoy SM; Pezo RC; Levsky JM; Singer RH; Augenlicht LH

    Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.

    CANCER RESEARCH 62 6006-6010. .

  • Mariadason JM; Arango D; Corner GA; Arañes MJ; Hotchkiss KA; Yang W; Augenlicht LH

    A gene expression profile that defines colon cell maturation in vitro.

    CANCER RESEARCH 62 4791-4804. .

  • Arango D; Ettarh RR; Holden G; Moriarty M; Brennan PC

    BB-10010, an analog of macrophage inflammatory protein-1alpha, protects murine small intestine against radiation.

    DIGESTIVE DISEASES AND SCIENCES 46 2608-2614. .

    [doi:10.1023/a:1012798606806]

  • Augenlicht LH; Wadler S; Arango D

    Clinical response to fluorouracil and p53.

    NEW ENGLAND JOURNAL OF MEDICINE 345 1065-1066. .

    [doi:10.1056/NEJM200110043451414]

  • Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH

    c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.

    CANCER RESEARCH 61 4910-4915. .

  • Stanton MT; Ettarh R; Arango D; Tonra M; Brennan PC

    Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine.

    LIFE SCIENCES 68 1471-1475. .

    [doi:10.1016/s0024-3205(01)00940-7]

  • Arango D; Ettarh RR; Brennan PC

    Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: single and double administration protocols.

    DIGESTIVE DISEASES AND SCIENCES 45 2306-2312. .

    [doi:10.1023/a:1005674505364]

  • Arango D; Ettarh RR; Brennan PC

    BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts.

    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 34 68-72. .

    [doi:10.1080/00365529950172853]

Proyectos

  • Contratos predoctorales de formación en investigación en salud (PFIS)
  • Nueva aproximación terapéutica para el cáncer colorectal.
  • EPH Receptor Signaling in Endometrial Cancer
  • Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
  • Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
  • Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
  • Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
  • Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
  • Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy